Adolescent Consent for HPV Vaccine: Ethical, Legal, and Practical Considerations
| dc.contributor.author | Zimet, Gregory D. | |
| dc.contributor.author | Silverman, Ross D. | |
| dc.contributor.author | Bednarczyk, Robert A. | |
| dc.contributor.author | English, Abigail | |
| dc.contributor.department | Pediatrics, School of Medicine | en_US |
| dc.date.accessioned | 2021-02-23T20:30:11Z | |
| dc.date.available | 2021-02-23T20:30:11Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Healthy People 2020 set a goal of 80% series completion for HPV vaccine. 1 The 2019 National Immunization Survey-Teen shows that 54.2% of adolescents aged 13-17 years were up-to-date with the vaccine series. 2 Although this coverage level represents an incremental increase over 2018, it remains well-below the Healthy People goal. Furthermore, HPV vaccine ordering and administration have dropped dramatically during the COVID-19 pandemic. | en_US |
| dc.eprint.version | Author's manuscript | en_US |
| dc.identifier.citation | Zimet, G. D., Silverman, R. D., Bednarczyk, R. A., & English, A. (2021). Adolescent Consent for HPV Vaccine: Ethical, Legal, and Practical Considerations. The Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2021.01.026 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/25276 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1016/j.jpeds.2021.01.026 | en_US |
| dc.relation.journal | The Journal of Pediatrics | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | Author | en_US |
| dc.subject | immunization | en_US |
| dc.subject | adolescent | en_US |
| dc.subject | minor consent | en_US |
| dc.title | Adolescent Consent for HPV Vaccine: Ethical, Legal, and Practical Considerations | en_US |
| dc.type | Article | en_US |